Similarly, in patients with diabetic cardiomyopathy, MR inhibitors not only prevent left-ventricular remodeling and expansion of fibrotic areas but also protect against myocardial injury [46]. The gene discussed is NR3C2; the disease is diabetic cardiomyopathy.